Abstract:Abstract CD8 + cytotoxic T cells (CTLs) orchestrate antitumour immunity and exhibit inherent heterogeneity 1,2 , with precursor exhausted T (T pex ) cells but not terminally exhausted T (T ex ) cells capable of responding to existing immunotherapies 3–7 . The gene regulatory network that underlies CTL differentiation and whether T ex cell responses can be functionally reinvigorated are incompletely understood. Here we systematically mapped causal gene regulatory networks using single-cell CRISPR screens in vivo and discovered checkpoints for CTL differentiation. First, the exit from quiescence of T pex cells initiated successive differentiation into intermediate T ex cells. This process is differentially regulated by IKAROS and ETS1, the deficiencies of which dampened and increased mTORC1-associated metabolic activities, respectively. IKAROS-deficient cells accumulated as a metabolically quiescent T pex cell population with limited differentiation potential following immune checkpoint blockade (ICB). Conversely, targeting ETS1 improved antitumour immunity and ICB efficacy by boosting differentiation of T pex to intermediate T ex cells and metabolic rewiring. Mechanistically, TCF-1 and BATF are the targets for IKAROS and ETS1, respectively. Second, the RBPJ–IRF1 axis promoted differentiation of intermediate T ex to terminal T ex cells. Accordingly, targeting RBPJ enhanced functional and epigenetic reprogramming of T ex cells towards the proliferative state and improved therapeutic effects and ICB efficacy. Collectively, our study reveals that promoting the exit from quiescence of T pex cells and enriching the proliferative T ex cell state act as key modalities for antitumour effects and provides a systemic framework to integrate cell fate regulomes and reprogrammable functional determinants for cancer immunity.

Hallmarks of T-cell Exit from Quiescence

Cellular and molecular waypoints along the path of T cell exhaustion

Integrative Proteomics and Phosphoproteomics Profiling Reveals Dynamic Signaling Networks and Bioenergetics Pathways Underlying T Cell Activation

Inhibition of E Protein Activity Facilitates the Quiescence Exit of Naïve CD4+ T Cells Through Modulating PI3K-AKT Signaling and TCR Microcluster Formation.

T Cell Receptor-Regulated TGF-β Type I Receptor Expression Determines T Cell Quiescence and Activation.

Cellular metabolism dictates T cell effector function in health and disease

Post-transcriptional regulation by TIA1 and TIAL1 controls the transcriptional program enforcing T cell quiescence

Quiescence of Memory CD8(+) T Cells Is Mediated by Regulatory T Cells through Inhibitory Receptor CTLA-4

Molecular and cellular insights into T cell exhaustion

The Translational Machinery of Human CD4+ T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic Remodeling

Mechanisms of T cell exhaustion guiding next-generation immunotherapy

T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications

From “truly naïve” to “exhausted senescent” T cells: When markers predict functionality

Cellular Metabolism On T-Cell Development And Function

T‐cell metabolism governing activation, proliferation and differentiation; a modular view

Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer

Exit from germinal center to become quiescent memory B cells depends on metabolic reprograming and provision of a survival signal

T Cell Anergy, Exhaustion, Senescence, and Stemness in the Tumor Microenvironment

MYB orchestrates T cell exhaustion and response to checkpoint inhibition

CD8+ T Cell Exhaustion in Cancer

Iron regulates the quiescence of naive CD4 T cells by controlling mitochondria and cellular metabolism